HUMA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 11.20%

Insider Buying (Last 12 Months): $389,301.20

Insider Selling (Last 12 Months): $25,940,916.90

Humacyte Insider Trading History Chart

Humacyte Share Price & Price History

^$1.96

▼ -0.05 (-2.49%)

As of 03/28/2025 05:00 PM ET

Days: 30 | 90 | 365

Humacyte Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/4/2024	Michael T. Constantino	Director	Buy	4,600	$4.39	$20,194.00	16,950
11/20/2024	Laura E. Niklason	CEO	Sell	261,369	$4.40	$1,150,023.60	1,730,884
11/19/2024	Brady W. Dougan	Director	Sell	427,459	$4.34	$1,855,172.06	1,992,253
11/18/2024	Laura E. Niklason	CEO	Sell	811,172	$4.44	$3,601,603.68	2,419,712
9/10/2024	Kathleen Sebelius	Director	Sell	5,182	$5.40	$27,982.80	40,276
9/9/2024	Laura E. Niklason	CEO	Sell	157,704	$5.42	$854,755.68	3,519,558
8/29/2024	Brady W. Dougan	Director	Sell	352,112	$6.35	$2,235,911.20	3,677,262
8/28/2024	Laura E. Niklason	CEO	Sell	277,090	$6.47	$1,792,772.30	4,029,374
8/27/2024	Brady W. Dougan	Director	Sell	252,676	$6.71	$1,695,455.96	4,306,464
8/27/2024	Dale A Sander	CFO	Sell	39,389	$6.68	$263,118.52	2,000
6/12/2024	Brady W. Dougan	Director	Sell	271,518	$7.30	$1,982,081.40	4,559,140
6/11/2024	Laura E. Niklason	CEO	Sell	358,630	$7.08	$2,539,100.40	4,830,658
6/4/2024	Brady W. Dougan	Director	Buy	2,362	$6.35	$14,998.70	240,832
6/3/2024	Laura E. Niklason	CEO	Buy	2,050	$7.37	$15,108.50	238,470
5/31/2024	Laura E. Niklason	CEO	Sell	809,786	$7.91	$6,405,407.26	5,381,354
5/30/2024	Heather Ledbetter Prichard	COO	Sell	188,886	$8.14	$1,537,532.04	2,625
5/15/2024	Gordon M Binder	Director	Buy	50,000	$6.78	$339,000.00	160,000
9/14/2023	Laura E. Niklason	CEO	Sell	2,000,000	$2.78	$5,560,000.00	6,191,140
8/21/2023	Laura E. Niklason	CEO	Sell	602,443	$3.39	$2,042,281.77	8,191,140
8/18/2023	Brady W. Dougan	Director	Sell	626,979	$3.57	$2,238,315.03	8,793,583
8/17/2023	Laura E. Niklason	CEO	Sell	570,174	$3.68	$2,098,240.32	9,420,562
6/15/2023	Laura E. Niklason	CEO	Sell	500,000	$3.12	$1,560,000.00	9,990,736
6/13/2023	Laura E. Niklason	CEO	Sell	4,875,000	$2.60	$12,675,000.00	10,490,736
5/25/2023	Heather Ledbetter Prichard	COO	Sell	9,613	$3.83	$36,817.79	64,566
5/25/2023	Laura E. Niklason	CEO	Sell	2,625,000	$2.75	$7,218,750.00	15,365,736
12/16/2022	Brady W. Dougan	Director	Sell	239,538	$2.53	$606,031.14	17,990,736
12/16/2022	Dale A Sander	CFO	Buy	20,000	$2.60	$52,000.00	20,600
12/15/2022	Laura E. Niklason	CEO	Sell	93,426	$2.63	$245,710.38	18,230,274
12/14/2022	Brady W. Dougan	Director	Sell	276,304	$2.76	$762,599.04	18,323,700
12/13/2022	Laura E. Niklason	CEO	Sell	330,000	$2.84	$937,200.00	18,600,004
12/13/2022	William John Scheessele	Insider	Buy	5,000	$3.09	$15,450.00	15,525
9/15/2022	Brady W. Dougan	Director	Sell	1,522,500	$4.00	$6,090,000.00	18,930,004
9/15/2022	Laura E. Niklason	CEO	Buy	2,000	$4.14	$8,280.00	1,160,240
5/24/2022	William John Scheessele	Insider	Buy	10,525	$4.72	$49,678.00	10,525
5/23/2022	Laura E. Niklason	CEO	Buy	10,000	$4.83	$48,300.00	1,158,240
5/23/2022	Michael T. Constantino	Director	Buy	2,000	$4.83	$9,660.00	4,500
5/17/2022	Dale A Sander	CFO	Buy	2,000	$4.53	$9,060.00	2,000

See Full Table

SEC Filings (Institutional Ownership Changes) for Humacyte (NASDAQ:HUMA)

44.71% of Humacyte stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Humacyte Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	202,825	$1.02M	0.0%	+85.2%	0.161%
2/17/2025	Voloridge Investment Management LLC	499,202	$2.52M	0.0%	-60.4%	0.397%
2/17/2025	Waverly Advisors LLC	274,579	$1.39M	0.0%	+331.9%	0.218%
2/17/2025	Woodline Partners LP	2,848,802	$14.39M	0.1%	+235.7%	2.263%
2/17/2025	Squarepoint Ops LLC	26,098	$0.13M	0.0%	N/A	0.021%
2/17/2025	Two Sigma Advisers LP	147,100	$0.74M	0.0%	-21.9%	0.117%
2/17/2025	Two Sigma Investments LP	919,097	$4.64M	0.0%	-14.0%	0.730%
2/17/2025	Rafferty Asset Management LLC	231,052	$1.17M	0.0%	-6.5%	0.184%
2/17/2025	ProShare Advisors LLC	30,852	$0.16M	0.0%	+30.4%	0.025%
2/17/2025	Nuveen Asset Management LLC	294,392	$1.49M	0.0%	-25.5%	0.234%
2/17/2025	Millennium Management LLC	918,854	$4.64M	0.0%	-27.5%	0.730%
2/17/2025	Deutsche Bank AG	78,474	$0.40M	0.0%	+50.8%	0.062%
2/17/2025	Crestline Management LP	12,976	$66K	0.0%	N/A	0.010%
2/17/2025	Cetera Investment Advisers	27,880	$0.14M	0.0%	+48.7%	0.022%
2/17/2025	Brevan Howard Capital Management LP	876,340	$4.43M	0.0%	+2,795.1%	0.696%
2/17/2025	Bank of America Corp DE	597,319	$3.02M	0.0%	+160.2%	0.475%
2/17/2025	BNP Paribas Financial Markets	14,613	$74K	0.0%	N/A	0.012%
2/17/2025	Ameriprise Financial Inc.	11,555	$58K	0.0%	N/A	0.009%
2/14/2025	Freestone Grove Partners LP	38,899	$0.20M	0.0%	N/A	0.031%
2/14/2025	Northern Trust Corp	901,194	$4.55M	0.0%	+11.5%	0.716%
2/14/2025	Beacon Pointe Advisors LLC	20,000	$0.10M	0.0%	+33.3%	0.016%
2/14/2025	Voya Investment Management LLC	26,291	$0.13M	0.0%	-10.4%	0.021%
2/14/2025	Syon Capital LLC	10,777	$54K	0.0%	N/A	0.009%
2/14/2025	Price T Rowe Associates Inc. MD	33,870	$0.17M	0.0%	+20.7%	0.027%
2/14/2025	Dark Forest Capital Management LP	42,875	$0.22M	0.0%	+43.1%	0.034%
2/14/2025	Hsbc Holdings PLC	12,417	$62K	0.0%	N/A	0.010%
2/14/2025	MetLife Investment Management LLC	44,960	$0.23M	0.0%	-14.0%	0.036%
2/14/2025	First Trust Advisors LP	340,552	$1.72M	0.0%	N/A	0.271%
2/13/2025	Marshall Wace LLP	54,917	$0.28M	0.0%	-90.6%	0.044%
2/13/2025	Rather & Kittrell Inc.	17,350	$88K	0.0%	N/A	0.014%
2/13/2025	Jump Financial LLC	93,763	$0.47M	0.0%	-71.4%	0.074%
2/13/2025	Rossby Financial LCC	25,000	$0.13M	0.1%	N/A	0.020%
2/13/2025	Walleye Capital LLC	106,698	$0.54M	0.0%	N/A	0.085%
2/13/2025	XTX Topco Ltd	43,929	$0.22M	0.0%	+29.0%	0.035%
2/13/2025	Barclays PLC	226,266	$1.14M	0.0%	-4.4%	0.180%
2/13/2025	Rockefeller Capital Management L.P.	49,662	$0.25M	0.0%	N/A	0.039%
2/13/2025	Petros Family Wealth LLC	10,000	$50K	0.1%	N/A	0.008%
2/13/2025	Quinn Opportunity Partners LLC	65,000	$0.33M	0.0%	N/A	0.052%
2/13/2025	Jaffetilchin Investment Partners LLC	67,200	$0.34M	0.0%	N/A	0.053%
2/13/2025	CenterBook Partners LP	1,279,839	$6.46M	0.4%	N/A	1.017%
2/13/2025	Raymond James Financial Inc.	74,698	$0.38M	0.0%	N/A	0.059%
2/13/2025	Legal & General Group Plc	81,405	$0.41M	0.0%	+19.5%	0.065%
2/13/2025	Wells Fargo & Company MN	50,454	$0.26M	0.0%	+40.9%	0.040%
2/12/2025	Uniting Wealth Partners LLC	39,554	$0.20M	0.1%	N/A	0.031%
2/12/2025	Geode Capital Management LLC	2,135,133	$10.79M	0.0%	+4.7%	1.696%
2/12/2025	Franklin Resources Inc.	433,482	$2.19M	0.0%	N/A	0.344%
2/11/2025	Corebridge Financial Inc.	43,702	$0.22M	0.0%	-7.0%	0.035%
2/11/2025	Vanguard Group Inc.	5,602,684	$28.29M	0.0%	+10.8%	4.452%
2/11/2025	LPL Financial LLC	529,992	$2.68M	0.0%	+3.5%	0.421%
2/11/2025	KLP Kapitalforvaltning AS	19,600	$99K	0.0%	N/A	0.016%
2/11/2025	Teacher Retirement System of Texas	26,200	$0.13M	0.0%	+25.3%	0.021%
2/11/2025	Intech Investment Management LLC	60,178	$0.30M	0.0%	+41.2%	0.048%
2/10/2025	Thrivent Financial for Lutherans	415,262	$2.10M	0.0%	+217.3%	0.330%
2/10/2025	Commonwealth Equity Services LLC	83,128	$0.42M	0.0%	+27.0%	0.066%
2/10/2025	Thompson Siegel & Walmsley LLC	35,000	$0.18M	0.0%	N/A	0.028%
2/10/2025	Swiss National Bank	172,100	$0.87M	0.0%	+5.8%	0.137%
2/7/2025	HighTower Advisors LLC	13,105	$66K	0.0%	N/A	0.010%
2/7/2025	Endowment Wealth Management Inc.	104,108	$0.53M	0.4%	+3.6%	0.083%
2/6/2025	Raymond James Financial Inc.	74,698	$0.38M	0.0%	N/A	0.059%
2/6/2025	Victory Capital Management Inc.	12,911	$65K	0.0%	-83.2%	0.010%
2/6/2025	Charles Schwab Investment Management Inc.	775,718	$3.92M	0.0%	+7.5%	0.616%
2/4/2025	Rowlandmiller & PARTNERS.ADV	31,500	$0.16M	0.0%	N/A	0.025%
2/3/2025	Private Advisor Group LLC	599,700	$3.03M	0.0%	+60.7%	0.476%
1/31/2025	Atria Wealth Solutions Inc.	25,840	$0.13M	0.0%	N/A	0.021%
1/30/2025	Rhumbline Advisers	114,455	$0.58M	0.0%	+4.6%	0.091%
1/30/2025	Vontobel Holding Ltd.	10,000	$50K	0.0%	N/A	0.008%
1/28/2025	LJI Wealth Management LLC	185,000	$0.93M	0.2%	N/A	0.147%
1/27/2025	Trilogy Capital Inc.	83,500	$0.42M	0.0%	N/A	0.066%
1/24/2025	China Universal Asset Management Co. Ltd.	27,282	$0.14M	0.0%	+18.8%	0.022%
1/22/2025	Wealth Effects LLC	121,400	$0.61M	0.2%	+89.1%	0.096%
1/22/2025	United Asset Strategies Inc.	184,208	$0.93M	0.1%	-15.6%	0.146%
1/17/2025	SG Americas Securities LLC	39,143	$0.20M	0.0%	+22.0%	0.031%
1/17/2025	ACT Wealth Management LLC	11,379	$57K	0.0%	N/A	0.009%
1/16/2025	ARS Investment Partners LLC	99,419	$0.50M	0.0%	+17.8%	0.079%
1/14/2025	Clarus Wealth Advisors	41,063	$0.21M	0.1%	N/A	0.033%
1/13/2025	Brookstone Capital Management	11,105	$56K	0.0%	N/A	0.009%
11/20/2024	Virtu Financial LLC	40,102	$0.22M	0.0%	-61.1%	0.032%
11/19/2024	Barclays PLC	236,742	$1.29M	0.0%	+177.6%	0.188%
11/16/2024	Geode Capital Management LLC	2,040,218	$11.10M	0.0%	+9.6%	1.709%
11/15/2024	Barclays PLC	236,742	$1.29M	0.0%	+177.6%	0.198%
11/15/2024	XTX Topco Ltd	34,049	$0.19M	0.0%	+48.8%	0.029%
11/15/2024	Insigneo Advisory Services LLC	20,000	$0.11M	0.0%	N/A	0.017%
11/15/2024	Wellington Management Group LLP	254,411	$1.38M	0.0%	+30.9%	0.213%
11/15/2024	State Street Corp	4,764,155	$25.92M	0.0%	+66.1%	3.992%
11/15/2024	Janus Henderson Group PLC	36,900	$0.20M	0.0%	N/A	0.031%
11/14/2024	Verition Fund Management LLC	90,240	$0.49M	0.0%	+459.1%	0.076%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	109,542	$0.60M	0.0%	N/A	0.092%
11/14/2024	FORA Capital LLC	17,731	$96K	0.0%	N/A	0.015%
11/13/2024	FMR LLC	94,387	$0.51M	0.0%	+28.5%	0.079%
11/13/2024	The Manufacturers Life Insurance Company	45,575	$0.25M	0.0%	+30.5%	0.038%
11/12/2024	Charles Schwab Investment Management Inc.	721,318	$3.92M	0.0%	+10.2%	0.604%
11/9/2024	Intech Investment Management LLC	42,615	$0.23M	0.0%	N/A	0.036%
11/7/2024	Thrivent Financial for Lutherans	130,894	$0.71M	0.0%	N/A	0.110%
11/5/2024	Victory Capital Management Inc.	76,896	$0.42M	0.0%	+551.6%	0.064%
11/5/2024	GSA Capital Partners LLP	120,318	$0.66M	0.0%	-46.3%	0.101%
10/31/2024	Concurrent Investment Advisors LLC	13,800	$75K	0.0%	N/A	0.012%
10/25/2024	China Universal Asset Management Co. Ltd.	22,955	$0.13M	0.0%	+64.1%	0.019%
10/22/2024	Private Advisor Group LLC	373,110	$2.03M	0.0%	+1.8%	0.313%
10/21/2024	Wealth Effects LLC	64,200	$0.35M	0.1%	N/A	0.054%
10/3/2024	SG Americas Securities LLC	32,074	$0.17M	0.0%	N/A	0.027%

Data available starting January 2016

See Full Table

Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; pediatric heart surgery; and coronary artery bypass grafting, as well as for the delivery of cellular therapy, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.

Today's Range

Now: $1.96

$1.76

$2.13

50 Day Range

MA: $3.61

$1.96

$4.72

52 Week Range

Now: $1.96

$1.76

$9.97

Volume

11,968,972 shs

Average Volume

3,333,918 shs

Market Capitalization

$246.68 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.36

Who are the company insiders with the largest holdings of Humacyte?: Humacyte's top insider investors include:
Laura E Niklason (CEO)
Brady W Dougan (Director)
Gordon M Binder (Director)
Heather Ledbetter Prichard (COO)
Kathleen Sebelius (Director)
Michael T Constantino (Director)
Dale A Sander (CFO)
Learn More about top insider investors at Humacyte.
Who are the major institutional investors of Humacyte?: Humacyte's top institutional shareholders include:
Vanguard Group Inc. — 4.45%
Woodline Partners LP — 2.26%
Geode Capital Management LLC — 1.70%
CenterBook Partners LP — 1.02%
Two Sigma Investments LP — 0.73%
Millennium Management LLC — 0.73%
Learn More about top institutional investors of Humacyte stock.
Which major investors are selling Humacyte stock?: In the last quarter, HUMA stock was sold by these institutional investors:
Voloridge Investment Management LLC
Marshall Wace LLP
Millennium Management LLC
Jump Financial LLC
Two Sigma Investments LP
Nuveen Asset Management LLC
Victory Capital Management Inc.
Two Sigma Advisers LP
Within the last year, company insiders that have sold Humacyte company stock include:
Laura E Niklason (CEO)
Brady W Dougan (Director)
Gordon M Binder (Director)
Heather Ledbetter Prichard (COO)
Kathleen Sebelius (Director)
Learn More investors selling Humacyte stock.
Which major investors are buying Humacyte stock?: In the previous quarter, HUMA stock was purchased by institutional investors including:
Woodline Partners LP
CenterBook Partners LP
Brevan Howard Capital Management LP
Vanguard Group Inc.
Franklin Resources Inc.
Bank of America Corp DE
First Trust Advisors LP
Thrivent Financial for Lutherans
In the last year, these company insiders have bought Humacyte stock:
Laura E Niklason (CEO)
Brady W Dougan (Director)
Gordon M Binder (Director)
Heather Ledbetter Prichard (COO)
Learn More investors buying Humacyte stock.